Jamshid Hadjati
Tehran University of Medical Sciences
H-index: 32
Asia-Iran
Top articles of Jamshid Hadjati
PX-478, an HIF-1α inhibitor, impairs mesoCAR T cell antitumor function in cervical cancer
Frontiers in Oncology
2024/2/15
Jamshid Hadjati
H-Index: 22
Hamid Reza Mirzaei
H-Index: 0
Anti-CTLA-4 nanobody as a promising approach in cancer immunotherapy
2024/1/8
Jamshid Hadjati
H-Index: 22
Crosstalk between autophagy and metabolic regulation of (CAR) T cells: therapeutic implications
2023/8/22
Jamshid Hadjati
H-Index: 22
Hamid Reza Mirzaei
H-Index: 0
Cell therapy is a distinguished targeted immunotherapy with great potential to treat solid tumors in the new era of cancer treatment. Cell therapy products include genetically …
Adoptive cellular therapies in immunoregulation and cancer
2023/7/5
Jamshid Hadjati
H-Index: 22
Ning Li
H-Index: 7
PGE2-EP2/EP4 signaling elicits mesoCAR T cell immunosuppression in pancreatic cancer
Frontiers in Immunology
2023/6/30
The inhibitory receptors PD1, Tim3, and A2aR are highly expressed during mesoCAR T cell manufacturing in advanced human epithelial ovarian cancer
Cancer Cell International
2023/5/27
Jamshid Hadjati
H-Index: 22
Hamid Reza Mirzaei
H-Index: 0
MicroRNA-124 Enhances T Cells Functions by Manipulating the Lactic Acid Metabolism of Tumor Cells
Iranian Journal of Allergy, Asthma and Immunology
2023/2/25
Soluble and immobilized anti-CD3/28 distinctively expand and differentiate primary human T cells: an implication for adoptive T cell therapy
Iranian Journal of Allergy, Asthma and Immunology
2022/12/24
Hamid Reza Mirzaei
H-Index: 0
Jamshid Hadjati
H-Index: 22
A novel formulation of cyclosporine A/phosphatidylserine-containing liposome using remote loading method: Potential product for immunosuppressive effects
Journal of Drug Delivery Science and Technology
2022/11/1
Amir Amani
H-Index: 22
Jamshid Hadjati
H-Index: 22
Alireza Partoazar
H-Index: 11
Mohammad Mashreghi
H-Index: 9
Remarkable Effect of Increasing Glutamine Metabolism on Caveolin-1 in Breast Cancer: A Brief Report
2022/9/23
Jamshid Hadjati
H-Index: 22
Zuhair Mohammad Hassan
H-Index: 23
Agent-based modeling of tumor and immune system interactions in combinational therapy with low-dose 5-fluorouracil and dendritic cell vaccine in melanoma B16F10
Iranian Journal of Allergy, Asthma and Immunology
2022/4/11
HIGHLY EFFICIENT GENERATION OF TRANSGENICALLY AUGMENTED CAR NK CELLS OVEREXPRESSING CXCR4
Frontiers in immunology
2020/8/28
Jamshid Hadjati
H-Index: 22
Hamid Reza Mirzaei
H-Index: 0
Identification of the optimal pattern of the injection and dosage of DC immunotherapy using the mathematical models based on ordinary differential equations
Iranian Journal of Immunology
2022
Targeting hypoxia and hypoxia‐inducible factor‐1 in the tumor microenvironment for optimal cancer immunotherapy
2022/2
Jamshid Hadjati
H-Index: 22
Extracting mutual interaction rules using fuzzy structured agent-based model of tumor-immune system interactions
Journal of Biomedical Physics & Engineering
2021/2
Prediction of anti-CD25 and 5-FU treatments efficacy for pancreatic cancer using a mathematical model
BMC cancer
2021/12
Sajad Shafiekhani
H-Index: 2
Hojat Dehghanbanadaki
H-Index: 2
Jamshid Hadjati
H-Index: 22
Amir Homayoun Jafari
H-Index: 11
CRISPR/Cas9-mediated TGFβRII disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells in vitro
Journal of translational medicine
2021/12
Khadijeh Alishah
H-Index: 5
Jamshid Hadjati
H-Index: 22
Genetic modification of cytokine signaling to enhance efficacy of CAR T cell therapy in solid tumors
2021/10/14
Epigenetic strategies to boost CAR T cell therapy
2021/9/1
Chimeric antigen receptor (CAR) T cell therapy for metastatic melanoma: challenges and road ahead
2021/6/9
Amirali Karimi
H-Index: 1
Ghanbar Mahmoodi Chalbatani
H-Index: 6
Jamshid Hadjati
H-Index: 22
Hamid Reza Mirzaei
H-Index: 0
